TXG
10x Genomics develops and sells advanced genomic analysis technologies that enable researchers to analyze biological samples at high resolution. Their products focus on single-cell sequencing and spatial transcriptomics to reveal cellular composition, interactions, and gene expression within tissues. They serve life sciences institutions globally, supporting cancer, immunology, neuroscience, and developmental biology research to advance human health. Headquartered in the United States, they provide instruments, reagents, and datasets to accelerate discoveries across research labs and clinical studies.
No recent deals for this company.